Torthaí cuardaigh - Robert C. Green

Beachtaigh na torthaí
  1. 1
    Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease<subtitle>A Randomized Controlled Trial</subtitle>

    Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease<subtitle>A Randomized Controlled Trial</subtitle> de réir Robert C. Green

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues

    Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues de réir Anna Lewis, Robert C. Green

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Regulation: The FDA is overcautious on consumer genomics

    Regulation: The FDA is overcautious on consumer genomics de réir Robert C. Green, Nita A. Farahany

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Direct to consumer genetic testing: Avoiding a culture war

    Direct to consumer genetic testing: Avoiding a culture war de réir James P. Evans, Robert C. Green

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Disclosing Secondary Findings from Pediatric Sequencing to Families: Considering the “Benefit to Families”

    Disclosing Secondary Findings from Pediatric Sequencing to Families: Considering the “Benefit to Families” de réir Benjamin S. Wilfond, Conrad V. Fernandez, Robert C. Green

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Genomic sequencing in clinical practice: applications, challenges, and opportunities

    Genomic sequencing in clinical practice: applications, challenges, and opportunities de réir Joel B. Krier, Sarah S. Kalia, Robert C. Green

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    An international policy on returning genomic research results

    An international policy on returning genomic research results de réir Anna Lewis, Bartha Maria Knoppers, Robert C. Green

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Polygenic risk scores in the clinic: Translating risk into action

    Polygenic risk scores in the clinic: Translating risk into action de réir Anna Lewis, Robert C. Green, Jason L. Vassy

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Reporting Genomic Sequencing Results to Ordering Clinicians

    Reporting Genomic Sequencing Results to Ordering Clinicians de réir Robert C. Green, James R. Lupski, Leslie G. Biesecker

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    How to know when physicians are ready for genomic medicine

    How to know when physicians are ready for genomic medicine de réir Jason L. Vassy, Bruce R. Korf, Robert C. Green

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq Consortium

    Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq Consortium de réir Michael D. Linderman, Daiva E. Nielsen, Robert C. Green

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Reconciling Opportunistic and Population Screening in Clinical Genomics

    Reconciling Opportunistic and Population Screening in Clinical Genomics de réir Kyle B. Brothers, Jason L. Vassy, Robert C. Green

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Assessing the Costs and Cost-Effectiveness of Genomic Sequencing

    Assessing the Costs and Cost-Effectiveness of Genomic Sequencing de réir Kurt D. Christensen, Dmitry Dukhovny, Uwe Siebert, Robert C. Green

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Communicating Genetic Risk Information for Common Disorders in the Era of Genomic Medicine

    Communicating Genetic Risk Information for Common Disorders in the Era of Genomic Medicine de réir Denise Lautenbach, Kurt D. Christensen, Jeffrey A. Sparks, Robert C. Green

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk

    Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk de réir Kurt D. Christensen, J. Scott Roberts, Wendy R. Uhlmann, Robert C. Green

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE Study

    Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE Study de réir Agustin Yip, Robert C. Green, Matthew Huyck, L. Adrienne Cupples, Lindsay A. Farrer

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    “I know what you told me, but this is what I think:” Perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate

    “I know what you told me, but this is what I think:” Perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate de réir Erin Linnenbringer, J. Scott Roberts, Susan Hiraki, L. Adrienne Cupples, Robert C. Green

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Consumers report lower confidence in their genetics knowledge following direct-to-consumer personal genomic testing

    Consumers report lower confidence in their genetics knowledge following direct-to-consumer personal genomic testing de réir Deanna Alexis Carere, Peter Kraft, Kimberly A. Kaphingst, J. Scott Roberts, Robert C. Green

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Prenatal DNA Sequencing: Clinical, Counseling, and Diagnostic Laboratory Considerations

    Prenatal DNA Sequencing: Clinical, Counseling, and Diagnostic Laboratory Considerations de réir Ahmad Abou Tayoun, Nancy B. Spinner, Heidi L. Rehm, Robert C. Green, Diana W. Bianchi

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Utilization of Genetic Counseling after Direct‐to‐Consumer Genetic Testing: Findings from the Impact of Personal Genomics (PGen) Study

    Utilization of Genetic Counseling after Direct‐to‐Consumer Genetic Testing: Findings from the Impact of Personal Genomics (PGen) Study de réir Diane R. Koeller, Wendy R. Uhlmann, Deanna Alexis Carere, Robert C. Green, J. Scott Roberts

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: